These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22977328)

  • 1. Determination of optimal imaging mode for ultrasonographic detection of subdermal contraceptive rods: comparison of spatial compound, conventional, and tissue harmonic imaging methods.
    Kim S; Seo K; Song HT; Suh JS; Yoon CS; Ryu JA; Park JS; Kim AH; Park AY; Kim Y
    Korean J Radiol; 2012; 13(5):602-9. PubMed ID: 22977328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound characteristics of subdermally implanted Implanon contraceptive rods.
    Lantz A; Nosher JL; Pasquale S; Siegel RL
    Contraception; 1997 Nov; 56(5):323-7. PubMed ID: 9437562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound versus fundamental imaging in the detection of subdermal contraceptive implants.
    Gabriel H; Shulman L; Marko J; Nikolaidis P; Chirita V
    J Ultrasound Med; 2007 Mar; 26(3):355-9. PubMed ID: 17324985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound localisation of non-palpable Implanon.
    Piessens SG; Palmer DC; Sampson AJ
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):112-6. PubMed ID: 15760310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sonographic localization of non-palpable implanon hormone implants].
    Prosch H; Walter RM; Westermayer V; Mostbeck GH
    Ultraschall Med; 2008 Dec; 29 Suppl 5():239-44. PubMed ID: 19177287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
    Power J; French R; Cowan F
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impalpable Implanon: a case report.
    Stillwell S; Sheppard P; Searle S
    J Fam Plann Reprod Health Care; 2003 Jul; 29(3):156-7. PubMed ID: 12885313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficult removal of subdermal contraceptive implants: a multidisciplinary approach involving a peripheral nerve expert.
    Odom EB; Eisenberg DL; Fox IK
    Contraception; 2017 Aug; 96(2):89-95. PubMed ID: 28583591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of conventional sonography, real-time compound sonography, tissue harmonic sonography, and tissue harmonic compound sonography of abdominal and pelvic lesions.
    Oktar SO; Yücel C; Ozdemir H; Ulutürk A; Işik S
    AJR Am J Roentgenol; 2003 Nov; 181(5):1341-7. PubMed ID: 14573431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
    Weisberg E; Croxatto HB; Findlay JK; Burger HG; Fraser IS
    Contraception; 2011 Dec; 84(6):600-8. PubMed ID: 22078189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound appearances of Implanon implanted contraceptive devices.
    McNeill G; Ward E; Halpenny D; Snow A; Torreggiani W
    JBR-BTR; 2009; 92(5):259-60. PubMed ID: 19999332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
    Teunissen AM; Grimm B; Roumen FJ
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound localisation and removal of non-palpable Implanon implants.
    James P; Trenery J
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):225-8. PubMed ID: 16704477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Traumatic Incomplete Fracture of an Implanon NXT® Contraceptive Implant.
    Howett R; Gertz AM; Kgaswanyane T; Petro G; Morroni C
    Afr J Reprod Health; 2019 Dec; 23(4):124-128. PubMed ID: 32227747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nexplanon(®): what Implanon(®) did next.
    Mansour D
    J Fam Plann Reprod Health Care; 2010 Oct; 36(4):187-9. PubMed ID: 21067632
    [No Abstract]   [Full Text] [Related]  

  • 18. Location and removal of non-palpable subdermal single-rod contraceptive implant.
    Buitrón-García-Figueroa R; Zancatl-Díaz ML; Basurto-Kuba EOP; Alvarez-Alfaro Ó
    Cir Cir; 2020; 88(4):485-488. PubMed ID: 32567592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical challenge with Implanon removal: a case report.
    Navani M; Robinson C
    J Fam Plann Reprod Health Care; 2005 Apr; 31(2):161-2. PubMed ID: 15921567
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonpalpable ultrasonographically not detectable Implanon rods can be localized by magnetic resonance imaging.
    Merki-Feld GS; Brekenfeld C; Migge B; Keller PJ
    Contraception; 2001 Jun; 63(6):325-8. PubMed ID: 11672555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.